Dr. Chen Junjie holds a Ph.D. in Pharmacology from the College of Medicine,Taiwan University. He served as Chief Scientific Officer (CSO) at iCarbonX Peptide Co., Ltd. and has experience holding key positions in multiple pharmaceutical companies such as Kexing Biopharm and Huarong Pharmaceutical.

With over 15 years of experience in new drug research and development, he possesses extensive drug R&D experience in various biopharmaceutical fields including peptides, small molecules, and antibodies. Having previously worked as a reviewer at the U.S. Food and Drug Administration (FDA), he can provide crucial guidance for clinical research of innovative drugs.